CoCites: A citation-based method for searching scientific literature

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

Jacques Barbet, Loïc Campion, Françoise Kraeber-Bodéré, Jean-François Chatal. J Clin Endocrinol Metab 2005
Times Cited: 228

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

Rossella Elisei, Valeria Bottici, Fabiana Luchetti, Giancarlo Di Coscio, Cristina Romei, Lucia Grasso, Paolo Miccoli, Pietro Iacconi, Fulvio Basolo, Aldo Pinchera, Furio Pacini. J Clin Endocrinol Metab 2004
Times Cited: 291

List of shared articles

Times cited

Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents.
Felix Eckelt, Roland Pfaeffle, Wieland Kiess, Juergen Kratzsch. J Pediatr Endocrinol Metab 2021

Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis.
Marisa A Bartz-Kurycki, Omowunmi E Oluwo, Lilah F Morris-Wiseman. Ther Adv Endocrinol Metab 2021

Clinical utility of ¹⁷⁷ Lu-DOTATATE PRRT in somatostatin receptor-positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity.
Rahul V Parghane, Chinna Naik, Sanjay Talole, Anuja Desmukh, Devendra Chaukar, Sharmila Banerjee, Sandip Basu. Head Neck 2020

Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma.
Xin Wu, Binglu Li, Chaoji Zheng, Wei Liu, Tao Hong, Xiaodong He. Technol Cancer Res Treat 2020

Management of Medullary Thyroid Cancer.
David Viola, Rossella Elisei. Endocrinol Metab Clin North Am 2019

Surgical management of medullary thyroid carcinoma.
Agathoklis Konstantinidis, Michael Stang, Sanziana A Roman, Julie Ann Sosa. Updates Surg 2017

THE COMBINED USE OF CALCITONIN DOUBLING TIME AND ¹⁸F-FDG PET/CT IMPROVES PROGNOSTIC VALUES IN MEDULLARY THYROID CARCINOMA: THE CLINICAL UTILITY OF ¹⁸F-FDG PET/CT.
Ji H Yang, Cléber P Camacho, Susan C Lindsey, Flavia O F Valente, Danielle M Andreoni, Lilian Y Yamaga, Jairo Wagner, Rosa Paula M Biscolla, Rui M B Maciel. Endocr Pract 2017

Charting a course through the CEAs: diagnosis and management of medullary thyroid cancer.
Christopher W Rowe, Cino Bendinelli, Shaun McGrath. Clin Endocrinol (Oxf) 2016

Response to initial therapy predicts clinical outcomes in medullary thyroid cancer.
Susan C Lindsey, Ian Ganly, Frank Palmer, R Michael Tuttle. Thyroid 2015

Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer.
Ji H Yang, Susan C Lindsey, Cléber P Camacho, Flávia O F Valente, Fausto Germano-Neto, Alberto L Machado, Maria Conceição O C Mamone, Fábio Brodskyn, Rosa Paula M Biscolla, Robert Michael Tuttle,[...]. Clin Endocrinol (Oxf) 2015

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015

1008

Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
Friedhelm Raue, Karin Frank-Raue. Recent Results Cancer Res 2015